Involvement of the orphan nuclear estrogen receptor-related receptor α in osteoclast adhesion and transmigration by Bonnelye, Edith et al.
Involvement of the orphan nuclear estrogen receptor-related
receptor a in osteoclast adhesion and transmigration
Edith Bonnelye
1,2, Fre ´de ´ric Saltel
1*
†, Anne Chabadel
1*, Ralph A Zirngibl
3,
Jane E Aubin
3 and Pierre Jurdic
1
1Institut de Ge ´nomique Fonctionnelle de Lyon, Universite ´ de Lyon, Universite ´ Lyon 1, CNRS, INRA, Ecole Normale Supe ´rieure de Lyon, 69007 Lyon, France
2INSERM U664, Faculte ´ de Me ´decine RTH Laennec, Rue Guillaume Paradin, 69372 Lyon Cedex 08, France
3Department of Molecular Genetics, Medical Sciences Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8
(Correspondence should be addressed to E Bonnelye at INSERM U664, Faculte ´ de Me ´decine RTH Laennec; Email: edith.bonnelye@inserm.fr)
*(F Saltel and A Chabadel contributed equally to this work)
†(F Saltel is now at European Institute of Chemistry and Biology, Unite ´ INSERM 889, Universite ´ Victor Segalen Bordeaux 2, IFR66, 2, rue Robert Escarpit,
33 600 Pessac, France)
Abstract
The orphan nuclear receptor, estrogen receptor-related receptor a (ERRa) is expressed in osteoblasts and osteoclasts
(OCs) and has been proposed to be a modulator of estrogen signaling. To determine the role of ERRa in OC biology, we
knocked down ERRa activity by transient transfection of an siRNA directed against ERRa in the RAW264.7 monocyte–
macrophage cell line that differentiates into OCs in the presence of receptor activator of nuclear factor kB-ligands and
macrophage colony-stimulating factor. In parallel, stable RAW cell lines expressing a dominant-negative form of ERRa
and greenﬂuorescentprotein (RAW-GFP-ERRaDAF2)wereused. Expression of OC markerswas assessedbyreal-time
PCR, and adhesion and transmigration tests were performed. Actin cytoskeletal organization was visualized using
confocal microscopy. We found that RAW264.7 cells expressing siRNA directed against ERRa and RAW-GFP-
ERRaDAF2 OCs displayed abnormal spreading, and decreased osteopontin and b3 integrin subunit expression
compared with the corresponding control cells. Decreased adhesion and the absence of podosome belts concomitant
with abnormal localization of c-src were also observed in RAW-GFP-ERRaDAF2-derived OCs. In addition, RAW-GFP-
ERRaDAF2-derived OCs failed to transmigrate through osteoblast cell layers. Our data show that the impairment of
ERRa function does not alter OC precursor proliferation and differentiation but does alter the adhesion/spreading and
migration capacities of mature OCs.
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Introduction
Osteoclasts (OCs) are large multinucleated cells of
hematopoietic origin formed by the differentiation and
fusion of mononuclear monocyte–macrophage lineage
precursors after stimulation by receptor activator of
nuclear factor kB-ligands (RANKL) and macrophage
colony-stimulating factors (M-CSF; Boyle et al. 2003).
OC formation is associated with the expression of
markers such as tartrate-resistant acid phosphatase
(TRAP) and calcitonin receptor (CTR). Moreover,
OCs are highly polarized cells, and several studies
have identiﬁed a series of factors involved in OC
spreading, polarity, adhesion, and migration, such as
osteopontin (OPN), integrin subunits av, b1, b3, b5,
cluster of differentiation 44 (CD44), c-src, and tumor
necrosis factor receptor-associated factor 6 (Traf6;
Denhardt & Noda 1998, Chellaiah & Hruska 2003,
Chabadel et al. 2007, Teitelbaum 2007). OCs are highly
migratory on bone surfaces or through collagen
(Domon et al. 2002, Delaisse et al. 2003, Saltel et al.
2004). Recently, we have found that OCs are also able to
transmigrate through cell layers, a process that involves
c-src and metalloproteinases (MMPs; Saltel et al. 2006).
Moreover, OCs exhibit several features, such as podo-
somes, that are associated with celladhesion, migration,
and invasion. In fact, we have previously shown that
matureOCs,whenspreadonglassorplastic,formhighly
dynamic podosome belts (Destaing et al. 2003, Jurdic
etal.2006)attheirperiphery;whereas,whenculturedon
apatite mineral (corresponding to the mineral phase of
bone), they exhibit another actin-rich structure, the
sealing zone, which seals off the resorption area
(Vaananen et al. 2000, Saltel et al. 2004, 2008).
Nuclear steroid receptors are transcription factors
involved in various physiological regulatory processes,
including multiple processes in bone (Gennari et al.
2007). The superfamily to which nuclear receptors
belong comprises both ligand-dependent molecules
such as ERs and a large number of so-called orphan
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determined (Benoit et al. 2006). Three orphan
receptors, ER-related receptor a (ERRa), ERRb, and
ERRg (NR3B1, NR3B2, and NR3B3 respectively,
according to the Nuclear Receptors Nomenclature
Committee 1999), share similarities with ERa and
ERb (NR3A1 and NR3A2 respectively; Green et al.
1986, Kuiper et al. 1996), but they do not bind estrogen
(Greschik et al. 2002, Kallen et al. 2004). Sequence
alignment of ERRa and the ERs reveals a high similarity
(68%) in the 66 amino acids (aa) of the DNA-binding
domain, but only a moderate similarity (36%) in the
ligand-binding domain, which may explain the fact that
ERRa recognizes the same DNA-binding elements as
ERs but does not bind estrogen (Giguere et al. 1988).
Several studies have shown that ERRa may activate gene
transcription constitutively essentially through its
coactivator-binding domain AF-2 (Vanacker et al. 1999,
Kallen et al. 2004). ERRa regulates fatty acid oxidation
and the adaptative bioenergetic response (Luo et al.
2003, Huss et al. 2007). ERRa is highly expressed in
skeletal (bone and cartilage) tissues (Bonnelye et al.
2001, 2007) and has been reported to regulate
osteoblast development and bone formation in vitro
(Bonnelye et al. 2001, 2007) and in vivo (Delhon et al.
2009, Teyssier et al. 2009). One study out of two has also
described an ESRRA gene regulatory variant that is
associated with bone mineral density and index in
premenopausal women (Laﬂamme et al. 2005, Giroux
et al. 2008).
In addition to its expression in osteoblasts, we have
previously described ERRa expression in multinucleated
TRAP-positive OCs in rat femurs after ovariectomy
(Bonnelye et al.2 0 0 2 ). We therefore decided to address
the possible function of ERRa in osteoclastogenesis,
including OC differentiation and adhesion–transmigra-
tion activities, using RAW264.7 cells transfected with an
siRNAdirectedagainstERRaorwithawild-type(WT)ora
dominant-negative form of ERRa.
Materials and methods
Reagents
A pEGFP vector (Clontech) was used to obtain the
stable RAW-GFP(Ct) and RAW-GFP-ERRaDAF2 (clones
1, 2, and 3) cell lines. Mouse ERRa cDNA (WT and
DAF2) was obtained fromm R N Ae x t r a c t e df r o m
primary OCs derived from spleen cells on day 6, using
reverse transcription (RT)-PCR with speciﬁc primers
((NM_007953.1): ERRa upstream (177 bp): TCC
AGC ACC ATG TCC AGC; ERRa downstream (WT)
(1–1436 bp): CCA CCC CTT GCC TCA GTC CAT;
ERRa downstream (DAF2): TCA TGC TGT CTG GCG
GA (1–1341 bp); helix 11–12 deletion (42 aa);
Bonnelye et al. 2007). Amplicons were sequenced for
veriﬁcation. Anti-phospho-src (pTyr418) was from
Abcam (ab4816); anti-integrin b3 chain was from BD
(San Jose, CA, USA); anti-GFP was from Roche
(monoclonal antibody mixture, clones 7.1 and 13.1).
CY5-conjugated secondary antibodies (anti-rabbit,
-mouse, -goat, and -hamster; 1/3000 ﬁnal dilution)
were from Jackson ImmunoResearch Laboratories
(West Grove, PA, USA). The F-actin distribution was
revealed with Alexa Fluor-546-Phalloidin from Molecu-
lar Probes (Eugene, OR, USA).
Cell culture
MC3T3-E1 cells were cultured in a-MEM containing
10% fetal bovine serum (FBS; Zirngibl et al. 2008). On
the day of transfection, cells were transfected using
Lipofectamine 2000 (Invitrogen). Spleen cells from
6-week-old OF1 male mice, none modiﬁed RAW264.7
and RAW264.7 (GFP(Ct) and GFP-DAF2) cells were
cultured for 8 and 6 days respectively in differentiation
medium: a-MEM containing 10% FCS (BioWest,
Nuaille, France), 20 ng/ml M-CSF and 20 ng/ml
soluble recombinant RANKL (Destaing et al. 2003).
RNA interference (siRNA)
The ERRa siRNA sequence was GCU AGU GCU CAG
CUC UCU ACC CAA (403–426 bp) (Invitrogen). This
sequence was rigorously analyzed by BLASTsearch, and
no homologies were found; this included no homology
with any of the ERa,E R b, ERRb, or ERRg, or with any
other currently known nuclear receptors. The rec-
ommended negative control (Sc) by the manufacturer
was used (Medium GC stealth RNA interference
negative control duplexes; Invitrogen). ERRa siRNA
and Sc were transfected twice into RAW cells following
the manufacturer’s protocol on days 3 and 4 after the
addition of RANKL. mRNA was extracted on day 5.
Transactivation assay
HeLa cells were plated at 40 000 cells/well on a 24-well
plate in DMEM (Sigma D5796) plus 10% FBS the day
before transfection and incubated in a humidiﬁed
incubator at 37 8C in a 95% air–5% CO2 atmosphere.
Media were changed just prior to transfection and again
24 h after transfection. Cells were transfected with
Lipofectamine 2000 (Invitrogen) following the manu-
facturer’s protocol using 100 ng expression vector,
200 ng luciferase reporter vector, and 10 ng pRL tk
luc (Promega) for normalization. The pGL3 BSP
reporter contains the rat bone sialoprotein promoter
from K448 to K1 relative to the transcription start site
cloned into pGL3B (Promega). Luciferase activities
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Microplate Luminometer LB96V (EG&G Berthold
GmbH & Co., Oak Ridge, TN, USA) using the Dual-
Luciferase reporter assay system (Promega). Transfec-
tions were repeated at least three times, and a
representative experiment is shown.
Osteoclast differentiation and spreading test
After 6 days, GFP(Ct) and GFP-DAF2 (1, 2, and 3) cells
were ﬁxed with paraformaldehyde (PFA; Merck), then
stained for TRAP using a histochemical kit (no. 387;
Sigma–Aldrich), following the manufacturer’s instruc-
tions. Multinucleated TRAP-positive cells containing
three or more nuclei were counted as OCs. To quantify
OCs spreading, OCs derived from GFP(Ct) and GFP-
DAF2 (1, 2, and 3) cells were ﬁxed and labeled with
Alexa Fluor-546-Phalloidin to visualize, by ﬂuorescence,
speciﬁc F-actin structure-containing podosome belts
that characterize spread OCs. Spread OCs were
quantiﬁed by counting the podosome belts versus the
total number of OCs, under a X40 (NA 1.0) Zeiss Plan-
Achromat objective and expressed as percentage.
Results were plotted as the mean percentage of
podosome belt number GS.D. of triplicate wells for
GFP(Ct)- and GFP-DAF2 (1, 2, and 3)-derived OCs and
for siRNA-transfected cells and are representative of two
independent experiments each.
Adhesion test
OCs were detached and re-seeded on plastic in 12-well
plates. The OCs were incubated at 37 8Ci nP B S
containing 0.25 mM EDTA (PBS–EDTA) 4 h later.
The incubation was stopped either immediately (TZ0)
or after 35 min (TZ35). Cultures were then ﬁxed
with PFA and stained for TRAP. Adhesion was
quantiﬁed by counting OCs that were still adherent at
TZ35 min versus the total number of OCs at TZ0 and
expressed as percentage. Results were plotted as the
mean percentage of adherent OCsGS.D. of triplicate
wells for GFP(Ct)- and GFP-DAF2 (1, 2, and 3)-derived
OCs and are representative of two independent
experiments.
Transmigration assay
A transmigrating OC is an OC that had been detached
and re-seeded on cell multilayers (for instance,
osteoblasts) and that in 12 h is able to cross the
osteoblast multilayers without destroying them and to
spread on the plastic substratum beneath the osteo-
blast. We used the osteoblastic cell line MC3T3-E1,
which we cultured for at least 1 week to obtain
multilayers of osteoblasts. At the end of the OC
differentiation process, OCs derived from GFP(Ct)
and GFP-DAF2 (1, 2, and 3) were removed and
re-seeded on the top of the multilayers of MC3T3-E1
cells as described previously (Saltel et al. 2006). Primary
OCs were also treated with echistatin at 10
K8 M
(Sigma–Aldrich) for 24 h, then seeded on MC3T3 in
the presence of echistatin at 10
K8 M for 12 h. Cells were
then ﬁxed after 20 min or 12 h, then permeabilized
with 0.2% Triton X-100 for 7 min, and stained with
Alexa Fluor-546-Phalloidin. OC transmigration efﬁ-
ciency was quantiﬁed using a X40 (NA 1.0) Zeiss
Plan-Achromat objective by counting the transmigrated
OCs versus the total number of OCs and expressed as
percentage. Results were plotted as the mean of the
number of the transmigrated OCsGS.D. of three wells
for GFP(Ct)- and GFP-DAF2 (1, 2, and 3)-derived OCs
and as the mean number of the transmigrated OCsG
S.D. of three wells for non-treated OCs and OCs treated
with echistatin. They are representative of three and
two independent experiments respectively.
RT-PCR
Total RNA was extracted with TRIzol reagent from OC
derived from spleen cells and RAW cells (GFP(Ct) and
GFP-DAF2 (1, 2, and 3)) and from siRNA-transfected
RAW cells. Samples of total RNA were reverse-
transcribed using SuperScript II retrotranscription kit
(Invitrogen; Bonnelye et al. 2001). Semi-quantitative
PCR was performed for all studied genes. Real-time
PCR was carried out to conﬁrm regulated genes found
by semi-quantitative PCR. Real-time RT-PCR was carried
out by using the LightCycler system (SYBR Green;
Qiagen) according to the manufacturer’s instructions.
PCRs were performed with the primers listed in Table 1,
and amplimers were all normalized to corresponding
L32 values. Data normalization: in real-time PCR, each
replicate average gene’s CT was normalized to the
average CT of L32 by subtracting the average CT of L32
f r o me a c hr e p l i c a t et og i v et h eDCT.R e s u l t sa r e
expressed as LogK2DDCT with DDCT equivalent to the
DCT of the genes in GFP-DAF2 (1, 2, and 3) or siRNA
subtracting to the DCT of the endogenous control
(GFP(Ct), Scramble respectively).
Western blotting
Total proteins were extracted (pools from three 35 mm
dishes for each condition) from RAW cells transfected
with GFP(Ct) or GFP-ERRa (ERRaWT or ERRaDAF2)
constructs according to the standard methods (Ausubel
et al. 1996). Western blot analyses were performed using
a semidry system. Immunoblotting was performed with
anti-GFP (Roche; monoclonal antibody mixture, clones
7.1 and 13.1). Blots were incubated overnight at
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at 1/100, and binding was detected using HRP-
conjugated rabbit anti-mice antibodies (1/3000;
Bio-Rad Laboratories) and chemiluminescence.
Immunoﬂuorescence
Cells were ﬁxed in 4% paraformaldehyde, pH 7.2 for
10 min, permeabilized with 0.2% Triton X-100 for
7 min, then incubated with antibodies and Alexa-
Fluor-546-Phalloidin as indicated. Cells were imaged
with a confocal Zeiss LSM 510, using a X63 (NA 1.4)
Plan Neoﬂuor objective. To prevent contamination
between ﬂuorochromes, each channel was imaged
sequentially, using the multitrack recording module,
before merging. Z-cut pictures were obtained using
Zeiss LSM 510 software.
Statistical analysis
Results for the real-time PCR analysis, the quantiﬁ-
cation of multinucleated TRAP-positive OCs, podo-
some belt numbers, adhesion, and transmigration were
expressed as meanGS.D., and analyzed statistically by
one-way ANOVA with the treatment group as variance
and by Student’s t-test with InStat software (version
2.01, GraphPad Software, San Diego, CA, USA).
Statistical signiﬁcance was taken as P!0.05 (Student’s
t-tests *P!0.05, **P!0.01, ***P!0.001).
Results
ERRa mRNA expression increased during osteoclast
differentiation in vitro
Consistent with our previous ﬁndings on the presence
of ERRa protein in multinucleated TRAP-positive cells
in rat femur in vivo (Bonnelye et al. 2002), we found, by
real-time PCR, ERRa mRNA expressed throughout all
the stages of OC differentiation: in primary leukocytes
extracted from spleen (day 0), proliferation (day 2),
mononucleated progenitor fusion (day 4), and matu-
ration (days 6–8) with signiﬁcant increases on days 4–8,
when multinucleated OCs were starting to form until
they reached maturity (Fig. 1A and B). For comparison,
mRNA levels for ERRb, ERRg,a n dt h el a t eO C
differentiation marker CTR were also assessed (Fig. 1A
and B). Interestingly and in contrast to ERRa, ERRg
mRNA expression decreased dramatically during OC
differentiation, while ERRb was not detected.
Table 1 Primers and conditions used for PCR
Gene Primers
PCR
cycles Temperature (8C) References
ERRa 50: CAGGAAAGTGAATGCCCAGG 24 55 Bonnelye et al. (2001)
30: CTTTGCAGCAAATATACATT
L32 50: CATGGCTGCCCTCCGGCCTC 24 55 Bonnelye et al. (2001)
30: CATTCTCTTCGCTGCGTAGCC
EGFP-C1 50: GTGAGCAAGGGCGAGGAGC 25 60 pEGFP-C1 (Clontech)
30: GGACTTGTACAGCTCGTCC
ERRa1188 50: GTGCACAGAGTCAGAATTGGC 34 55 NM_007953
ERRg 50: ACCATGAATGGCCATCAGAAC 35 59 Cheung et al. (2005)
30: ACCAGCTGAGGGTTCAGGTAT
c-fms 50: TGCTGAAGTGGGAGGGAGAG 24 55 BC043054
30: CTGTAGTCTAAGCATCTGTC
OPN 50: GGTGATAGCTTGGCTTATGG 24 55 AF515708
30: CCTCTTCTTTAGTTGACC
Integrin b3( b3)5 0: CTTTAAGAAGGAGTGTGTGG 28 55 NM_016780
30: GGTCTCATTAAGTCCCC
Integrin b1( b1)5 0: GAGACATGTCAGACCTGCC 25 55 BC050906
30: CCTGAGTAGGATTCATTTTCC
Cyclin D1 50: GCTTCTGGTGAACAAGCTC 30 58 BC044841
30: GTGGGCGTGCAGGCCAGACC
TRAP 50: TTCCTCCAGGATGGATTCATGG 21 55 NM_007388
30: CTGAAGATACTGCAGGTTGTGG
CTR 50: CGAACCTGGTCCAACTATACT 28 55 NM_007588
30: CCCTGGAAATGAATCAGAGAG
cytc1 50: ATTTCAACCCTTACTTTCCCG 24 59 Herzog et al. (2006)
30: CCACTTATGCCGCTTCATGGC
Integrin b5( b5)5 0: AGATGAGGTGATCACGTGGG 29 55 BC058246
30: GACAGTGTGTGTGGAGATGG
Integrin aV( av)5 0: GCAGATCACCTGCCAGG 27 55 NM_008402
30: CTTGCTCTTCTTGAGGTGG
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expressed during OC differentiation of the RAW264.7
macrophage cell line, although fold changes in the
expression level are less than that observed in primary
OC cultures, which is probably due to the fact that
RAW264.7 cells are already committed into the
macrophage lineage (Fig. 1C). Given its expression in
mature OCs, we then checked whether ERRa was
involved in their function.
Down-regulation of ERRa inhibits OPN and integrin
b3 expression in RAW264.7-derived osteoclasts
To check the involvement of ERRa in OC function, we
used a truncated version of ERRa lacking the coacti-
vator-binding domain AF2, ERRaDAF2, which acts as a
dominant-negative form of the receptor (Vanacker et al.
1999, Bonnelye et al. 2007). We ﬁrst conﬁrmed that
GFP-ERRaDAF2 acts dominant-negatively on the
expression of OPN, an ERRa target gene in osteoblasts
(Vanacker et al. 1998,Zirngibl et al. 2008,Teyssier etal. 2009),
in the MC3T3-E1 cell model (Fig. 2A). GFP-ERRaWT was
also made and transiently transfected with GFP-
ERRaDAF2 into the RAW264.7 macrophage cell line.
Protein size was evaluated by western blotting with a
GFP antibody, which detected a protein of w80 kDa
resulting from the fusion of the GFP (30 kDa) with the
ERRaWT protein (around 53 kDa) used as a size
control (Fig. 2B). As expected, a band of slightly
lower molecular weight was detected in GFP-ERRa
DAF2 cells, corresponding to the truncation of the AF2
domain (42 aa; Fig. 2B). Finally, we conﬁrmed the
efﬁcacy of GFP-ERRaWT and GFP-ERRaDAF2 con-
structs by luciferase reporter assay with a (K448 to
K1 bp) BSP promoter fragment (pGL3BSPLuc), an
ERRa target gene in osteoblasts (Bonnelye et al. 2001),
in HeLa cells (Fig. 2C). RAW264.7 cells were then stably
transfected with the GFP vector alone, which served as
control (Ct), and the dominant-negative GFP-ERRa
DAF2 constructs. Three independent RAW-GFP-ERRa
DAF2 (1, 2, and 3) and one GFP alone clone were
obtained, namely GFP-DAF2 (1, 2, and 3) and GFP(Ct)
respectively. GFP expression was tested with speciﬁc
GFP primers after 3 days of culture at the end of the
proliferation stage (Fig. 2D and Table 1). GFP mRNA
expression was observed in GFP(Ct) and all the three
stable clones GFP-DAF2 (1, 2, and 3), with lower GFP
expression in GFP-DAF2 (1, 2, and 3) versus GFP(Ct)
cells (Fig. 2D). As expected, a band of 1.7 kb was
ampliﬁed with GFP (50) and ERRa (30) primers in the
RNA isolated from GFP-DAF2 (1, 2, and 3) cells,
whereas no band was detected in GFP(Ct) cells
(Fig. 2D). GFP-ERRaDAF2 expression was estimated
to be tenfold less than the expression of the
endogenous ERRa. Moreover, by using a GFP antibody,
ERRa was localized by immunoﬂuorescence in mature
OCs derived from GFP(Ct) and GFP-DAF2 (1, 2, and 3)
cells (Fig. 4C and G). As expected, ERRaDAF2 was
detected in both the nucleus and the cytoplasm of GFP-
DAF2-2-derived OCs (Fig. 4G; similar results were
obtained for GFP-DAF2-1 and -3), whereas no GFP was
detected in the nucleus of GFP(Ct)-derived OCs
(Fig. 4C). Also as expected, the expression level of the
ERRatargetgenes,cytochromec-1(cytc;Hussetal.2007)
and OPN, was signiﬁcantly reduced in all the three
GFP-DAF2 clones in comparison with GFP(Ct) cells
(Fig. 2E–G), conﬁrming the dominant-negative func-
tion of the truncated ERRaDAF2 construct. Interest-
ingly, the expression of ERRg, which was expressed at
only undetectable to very low levels in RAW264.7 cells,
wasmarkedlyincreasedintwoofthreeGFP-DAF2clones
in comparison with GFP(Ct) cells (Fig. 2G).
To determine whether ERRa is involved in OC
formation, GFP-DAF2 (1, 2, and 3) and GFP(Ct) cells
were differentiated into mature multinucleated OCs in
the presence of M-CSF and RANKL. Based on the cell
counts after 3 days of culture, at the end of the
proliferation stage, reduction of ERRa transactivation
capacity had no effect on cell proliferation (data not
shown). Concomitantly, the expression of early markers
of OC differentiation, such as TRAP, c-fms, and RANKL
(data not shown), and of the proliferation marker
cyclin D1 was not affected (Fig. 2E and F). Later during
differentiation, while the OPN expression was still
down-regulated,wefoundthatintegrinb3chainexpres-
sion was also decreased in GFP-DAF2 (1, 2, and 3)
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Figure 1 ERRa is expressed during OC differentiation. (A and B)
Real-time PCR showed that ERRa is expressed in leukocytes
freshly isolated from murine spleen (d0), as well as during
osteoclastogenesis (d6–d8). ERRa and ERRg expression were
normalized against that of the ribosomal protein gene L32. For
comparison, the mRNA level for CTR is also shown. (C)
Consistent with primary cells, ERRa is also expressed during OC
formation from RAW264.7 cells. d, days in culture.
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hand, the expression of av, b1 and b5 integrin chain
subunits, c-src, CD44, and Traf6 was not affected
(Fig. 3A, and data not shown). Moreover, no differences
were observed in the expression of OC factors involved
in OC fusion (dendritic cell-speciﬁc transmembrane
protein DC-STAMP (DCS)) or apoptosis (Bcl2 and
Bax) in GFP-DAF2 (1, 2, and 3)- versus GFP(Ct)-derived
OCs (Fig. 3A).
To conﬁrm the putative functional role of ERRa
in OC as suggested by the results with the dominant-
negative form of ERRaDAF2, we then checked
whether the expression of OPN and integrin b3 chain
would be similarly altered by the overexpression of
ERRaWT or by an siRNA directed against ERRa.
Transient transfection of ERRaWT in RAW264.7 cells
at day 3 (transfection efﬁciency was very low at earlier
stages) up-regulated the expression of OPN and
integrin b3 chain at 48 h (Fig. 3B). On the other
hand, ERRa siRNA elicited a 60% decrease in the ERRa
expression level at day 5 (Fig. 3C). OPN as well as
integrin b3 expression was also down-regulated in OCs
derived from ERRa siRNA-transfected RAW cells
compared with control-transfected cells (Sc). Moreover,
ERRg expression was higher in ERRa siRNA-treated
cells (Fig. 3C), consistent with the results in GFP-DAF2
(1, 2, and 3)-derived OCs (cf. Fig. 2). Taken together,
these data suggest that ERRa does not play a role in the
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to OCs, but may be involved in their adhesion,
spreading, or migration activities.
Disruption of ERRa function inhibits OC spreading
and formation of podosome belts in RAW264.7-
derived osteoclasts
To unravel the function of ERRa in OCs, GFP-DAF2
(1, 2, and 3) and GFP(Ct) RAW cells were differentiated
into mature multinucleated OCs in the presence of
M-CSF and RANKL. After 6 days, no difference was
observed between the number of large multinucleated
TRAP-positive OCs and between the nuclei number in
GFP-DAF2 (1, 2, and 3) versus GFP(Ct) cells, suggesting
that ERRa does not affect OC differentiation from
macrophages (Fig. 4I–J). However, TRAP-positive
GFP-DAF2-2-derived OCs (Fig. 4E) appeared less spread
than TRAP-positive GFP(Ct)-derived OCs (Fig. 4A).
This morphological difference was well correlated to
their actin cytoskeletal organization. Indeed, well
spread GFP(Ct)-derived OCs exhibited a typical podo-
some belt (Fig. 4B, D and K), whereas in less spread
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organized as clusters or small rings (Fig. 4F, H and K).
Similar results were obtained in RAW cells transfected
with ERRa siRNA versus Sc siRNA or non-transfected
cells (Fig. 4L). Together with the down-regulation of
both OPN and b3 integrin chain, these latter results
strongly suggest that ERRa is involved in OC adhesion.
Disruption of OC adhesion and transmigration:
implication of integrin b3 in GFP-DAF2-derived OC
Down-regulation of b3e x p r e s s i o ni nG F P - DAF2-2-
derived OCs at day 6 (Fig. 3A) was conﬁrmed by
immunoﬂuorescence using an antibody against
integrin b3( Fig. 5A and D). As expected, intense b3
integrin subunit staining was localized around the actin
core of podosomes organized in a belt in GFP(Ct)-
derived OCs at day 6 (Fig. 5A and B, see merged in
Fig. 4C). In contrast, labeling for b3 integrin subunit
protein was diffusely distributed within GFP-DAF2-2-
derived OCs at day 6 (Fig. 5D and E, see merged in F).
Since we, and others, have shown the importance of
c-src in integrin signaling for actin organization, we
looked for phosphorylated c-src localization in OCs
expressing the dominant-negative form of ERRa.
Whereas phosphorylated c-src was distributed around
the podosome belt in GFP(Ct)-derived OCs on day 6
(Fig. 5G and H, see merged in I), it was diffusely
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in L). Similarly, vinculin localization was disrupted in
GFP-DAF2 cells (data not shown) compared with
GFP(Ct)-derived OCs at day 6. These results suggest
that disturbing ERRa function impairs a signaling
pathway linked to OPN, integrin b3, activated c-src,
and actin organization. Moreover, and in agreement
with the decrease in mature OC spreading, we observed
a decrease in OC adhesion in GFP-DAF2 (1, 2, and 3)-
derived OCs compared with GFP(Ct)-derived cells (by
40% in DAF2-1, 50% in DAF2-2, and 68% in DAF2-3
compared with GFP(Ct); Fig. 5M). It was observed that
the differences in OC viability, as reﬂected by OC
number, cannot account for the differences in spread-
ing between GFP(Ct)- and GFP-DAF2 (1, 2, and 3)-
derived OCs (TZ0; Fig. 5N).
To address further the consequences of disrupting
the actin structure due to the expression of a dominant-
negative form of ERRa in OCs, we then checked
whether OC transmigration was affected (Saltel et al.
2006). To this end, mature GFP-DAF2 (1, 2, and 3)- and
GFP(Ct)-derived OCs were seeded onto conﬂuent
osteoblastic MC3T3-E1 cells. After 20 min, large
rounded OCs (identiﬁed by GFP expression in green,
white arrows) derived from GFP-DAF2 (1, 2, and 3)
(Fig. 6G, see Z-cut section E) and GFP(Ct) (Fig. 6C, see
Z-cut section A) cells were localized on the top of
conﬂuent osteoblastic MC3T3-E1 cell layers (red, see
white asterisk). After 12 h, OCs derived from GFP(Ct)
cells were well spread and attached to the substratum
beneath the osteoblasts (Fig. 6D, and Z-cut section in
B), showing that they had transmigrated through the
MC3T3-E1 cell layers. In contrast, after 12 h of culture,
OCs derived from GFP-DAF2-2 cells appeared ‘frozen’
on the top of the MC3T3-E1 cell layers where they
maintained a rounded shape (Fig. 6H, see GFP-positive
OCs (white arrow) and Z-cut section in Fig. 6F). Similar
observationswereobtainedforGFP-DAF2clones1and3
20min
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Figure 6 Transmigration ability is decreased in GFP-DAF2-derived OCs. GFP(Ct)
(A–D, green) and GFP-DAF2-2-derived OCs (E–H, green) were seeded on the top of
MC3T3-E1 cells (red). Z-cut sections show that 20 min after seeding, OCs were lying
on the top of MC3T3-E1 cells (A and E). Control OCs had transmigrated down
through the osteoblastlayer 12 h after seeding(B), whereas GFP-DAF2-derived OCs
had not (F). (I) Inhibition of transmigration in GFP-DAF2 (1, 2, and 3)- versus
GFP(Ct)-derived OCs was quantiﬁed. (J) OC viability was evaluated by counting the
total number of OCs used in the transmigration assay. (K) Inhibition of transmigration
was also observed when mature OCs were treated with echistatin. (I and K) Results
represent the mean (%) of the transmigrated OC/total OC numberGS.D. for triplicate
determinations. (I) ANOVA; PZ0.001. (K) ANOVA; PZ0.0004. BarZ20 mm.
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versus non-transmigrated OCs conﬁrmed a signiﬁcant
decrease (72% in DAF2-1, 63% in DAF2-2, and 67% in
DAF2-3) in the transmigrated OC numbers in GFP-
DAF2 (1, 2, and 3)- compared with GFP(Ct)-derived
OCs (Fig. 6I). Viability of the transmigrated GFP(Ct)-
and GFP-DAF2 (1, 2, and 3)-derived OCs is equivalent
(total OC number at TZ12 h; Fig 6J). Interestingly, the
inhibition of transmigration observed with the knock-
down of ERRa correlated with that observed after
blocking integrins with echistatin, an RGD disintegrin,
in primary OCs re-seeded onto conﬂuent osteoblastic
MC3T3-E1 cells (Fig. 6K).
Discussion
We report that the overexpression or knockdown of
ERRa function in the RAW264.7 macrophage cell line
either by stable transfection of a dominant-negative
form of ERRa, GFP-ERRaDAF2 or by ERRa siRNA leads
tomodulationof theexpressionofOPNandb3integrin
subunit with concomitant actin cytoskeletal disorgani-
zation in the podosome belt, reduced adhesion on
tissue culture plastic or glass, and reduced transmigra-
tion activity. Although ERRa knockout mice and cells
are now available, our work was initiated when these
were not available, and both our stable and transient
knockdown approaches gave comparable and highly
reproducible results. It is therefore not clear why no
detectable alteration in the OC parameters was
observed in ERRa knockout mice (Delhon et al. 2009,
Teyssier et al. 2009), but it seems likely that compensa-
tory mechanisms involving ERRg may be operating,
since we found that ERRg is expressed in RAW264.7
cells when ERRa function is disrupted.
The molecular basis for the ERRa effect on cell
mobility is of interest because OPN, which is expressed
in several motile cell types including OCs and many
tumor cell lines (Standal et al. 2004), has been
described as a target gene of ERRa in promoter
reporter assays in vitro (Vanacker et al. 1998, Zirngibl
et al. 2008). OPN is involved in cell adhesion and
migration and promotes cell attachment to bone
(Denhardt & Noda 1998). Adhesion receptors avb1,
avb3, and avb5 integrins and the hyaluronan receptor
(CD44) are all receptors for OPN, and their
interactions are crucial for OC adhesion and motility
(McHugh et al.2 0 0 0 , Chellaiah & Hruska 2003).
Notably, OPN is known to stimulate glass-adherent
OC migration through the avb3 integrin-induced
activation of c-src and actin cytoskeletal reorganization
into podosome belts (Duong et al. 1998). While av, b1,
and b5 integrin subunits and CD44 were not affected
by the changes in ERRa activity, the expression of the
b3 integrin subunit was down-regulated in siRNA and
GFP-DAF2-derived OCs. In addition, more detailed
studies in GFP-DAF2-derived OCs showed that the
disruption of podosome belt formation was accom-
panied by an aberrant/diffuse distribution of the b3
integrin subunit, activated c-src, and vinculin. Thus, it is
likely that the inhibition of adhesion and disruption of
the podosome belt observed in GFP-DAF2-derived OCs
is a consequence of the reduced expression of both
OPN and b3 that consequently induced the disrupted
localization of activated c-src. Moreover, although
neither of the latter is known to be involved in OC
transmigration, the fact that avb3i si n v o l v e di n
monocyte transendothelial migration, that echistatin,
an RGD disintegrin, induces a decrease in OC
transmigration, and that c-src is involved in OC
transmigration through MC3T3-E1 cell layers suggests
that the b3 integrin subunit may be involved in OC
transmigration (Weerasinghe et al. 1998, Saltel et al.
2006). Indeed, in the presence of PP2, a c-src inhibitor,
OCs maintain a rounded shape and sit on the top of
MC3T3-E1 cell layers (Saltel et al. 2006) in a manner
similar to GFP-DAF2-derived OCs. These data suggest
that the disruption of activated c-src localization
may, at least in part, be due to down-regulated OPN
and/or integrin subunit b3 expression and may be
responsible for the inhibition of transmigration in
GFP-DAF2-derived OCs.
We have previously shown that ERRa positively
regulates osteoblast formation in rat calvarial cells
in vitro, acting at multiple developmental times to
regulate both proliferation and differentiation events
(Bonnelye et al. 2001). However, more recent data with
ERRa knockout mice and with human bone marrow
stromal cells suggest that ERRa may play a negative
regulatory role in other models or at other develop-
mental times (Delhon et al. 2009, Teyssier et al. 2009).
Further complicating the issue, one study suggests that
an ESRRA gene regulatory variant leading to increased
ERRa expression is associated with increased bone
mineral density in premenopausal women (Laﬂamme
et al. 2005), although a recent report has failed to
conﬁrm the observation (Giroux et al. 2008). Such
apparently complex and multiphasic activities, compli-
cated by potential compensatory mechanisms involving
other ERR family members, are in keeping with our
current data showing that down-regulation of ERRa
decreases OC transmigration, suggesting that ERRa
may positively regulate OC migration. Altogether, the
data suggest that ERRa may contribute to bone
homeostasis not only through effects on osteoblast
lineage cells but also on OCs.
ERRa expression in other highly motile cells such as
dendritic cells and macrophages (Sonoda et al. 2007,
Bonnelye et al. 2008) supports a role for ERRa in
inﬂammatory diseases associated with osteoclastic bone
degradation such as rheumatoid arthritis and other
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(Wilder 2002, Yumoto et al. 2002). In this regard,
recently, and similarly to our data on OC migration,
siRNA-mediated knockdown of ERRa in the highly
aggressive breast carcinoma MDA-231 cell line resulted
in a dramatic decrease in their migration (Stein et al.
2008). We thus hypothesize that the ERRa-regulated
OPN and integrin subunit b3 pathway that we described
here may also be operative in cancer cells.
In conclusion, ERRa is expressed in OCs where it
regulates the expression of OPN and integrin subunit
b3, and plays a role in the spreading, organization,
and/or stabilization of podosomes at the cell periphery,
as well as in the adhesion and transmigration in a RAW
cell culture model in vitro. Further understanding of
the mechanisms by which ERRa modulates migration
in the normal development and disease is required. In
the meantime, our data suggest that the regulation of
ERRa activity may provide a new therapeutic strategy
for inﬂammatory and bone diseases associated with
an imbalance in bone remodeling due to excessive
OC resorption.
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